Results 111 to 120 of about 2,050,369 (162)
Editorial: Achilles heel of CAR T-cell therapy. [PDF]
Front ImmunolChiriva-Internati M, Grizzi F.
europepmc +1 more source
Correction to: CAR NK cell therapy for solid tumors: potential and challenges. [PDF]
Antib Thereuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Clinics of North America: Small Animal Practice, 2019
The necessity of improving the health and quality of life of subjects affected by diverse injuries and chronic diseases, has led to develop a new branch of translational medicine, called Regenerative Medicine (RegMed). RegMed has the principal objects of restoring, maintaining or enhancing structures and functions of tissues and organs.
De Falco E. +3 more
openaire +3 more sources
The necessity of improving the health and quality of life of subjects affected by diverse injuries and chronic diseases, has led to develop a new branch of translational medicine, called Regenerative Medicine (RegMed). RegMed has the principal objects of restoring, maintaining or enhancing structures and functions of tissues and organs.
De Falco E. +3 more
openaire +3 more sources
2007
T cell therapies are increasingly used for the treatment of malignancies and viral-associated diseases. Initial studies focused on the use of unmanipulated T cell populations after allogeneic stem cell transplantation. More recently, the use of antigen-specific T cells has been explored.
S, Gottschalk +8 more
openaire +2 more sources
T cell therapies are increasingly used for the treatment of malignancies and viral-associated diseases. Initial studies focused on the use of unmanipulated T cell populations after allogeneic stem cell transplantation. More recently, the use of antigen-specific T cells has been explored.
S, Gottschalk +8 more
openaire +2 more sources
Cell therapy commercialisation
2012‘Cells as therapies’ is a major step change in healthcare. Living cells offer solutions for a range of currently incurable medical conditions; however, both the technology and its essential infrastructure are far from market ready. Despite the limitations of any fledgling technology, the global cell therapy industry (CTI) has already achieved a billion-
Brindley, D, Mason, C
openaire +1 more source
Science, 2018
Synthetic Notch receptors expand the therapeutic potential of engineered T ...
openaire +2 more sources
Synthetic Notch receptors expand the therapeutic potential of engineered T ...
openaire +2 more sources